HanmoBio Completes Cell Processing Facility Approval... "Accelerating Hair Loss Treatment"
Cell or Tissue Testing and Processing, Supply to Regenerative Medical Institutions Possible
Hanmo Bio (CEO Yoon Jung-in) announced on the 1st that it has received approval for a 'cell processing facility under the Advanced Regenerative Bio Act' from the Ministry of Food and Drug Safety. Photo by Hanmo Bio
View original image[Asia Economy Reporter Kim Heeyoon] Hanmo Bio (CEO Yoon Jung-in) announced on the 1st that it has received approval for a 'cell processing facility under the Advanced Regenerative Bio Act' from the Ministry of Food and Drug Safety.
With this approval, Hanmo Bio can now conduct testing and processing of cells or tissues such as stem cells, hematopoietic stem cells, somatic cells, and immune cells collected from medical institutions, and supply them to regenerative medical institutions.
Since the enforcement of the Advanced Regenerative Bio Act, out of approximately 3,000 bio companies in Korea, only 14 companies have been granted cell processing facility permits. Excluding companies that were approved under the previous Pharmaceutical Affairs Act, five companies including Hanmo Bio have been newly approved as cell processing facilities.
Kang Dawit, Chairman of Han Bio Group, stated, "With the recent initiation of non-clinical trials and this cell processing facility approval, Hanmo Bio is closer to fundamentally and completely solving the problem of hair loss, which is our goal," adding, "We will lead the hair loss market through various technology developments and research going forward."
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- Jinwoo Sunim: "We Must Abandon the Extremes of Surviving by Defeating Others"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Hanmo Bio is an affiliate of Han Bio Group, a specialized cell bio company. Based on accumulated cell culture technology, it succeeded in mass culturing from one hair papilla cell to 30,000 cells, and filed a patent for the cultured hair papilla cell transplantation method along with this technology. Earlier in October, it entered non-clinical trials through a comprehensive clinical contract with a CRO (Contract Research Organization) company.
Hanmo Bio (CEO Yoon Jung-in) announced on the 1st that it has received approval for a 'cell processing facility under the Advanced Regenerative Bio Act' from the Ministry of Food and Drug Safety. Photo by Hanmo Bio
View original image© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
